2023
DOI: 10.1007/s00213-023-06340-8
|View full text |Cite
|
Sign up to set email alerts
|

Rate of onset of dopamine transporter inhibitors assessed with intracranial self-stimulation and in vivo dopamine photometry in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 51 publications
1
2
0
Order By: Relevance
“…Our result is similar to the prior finding that both α-PBT and α-PVP facilitate ICSS responses. , In general, a reduced ICSS threshold is considered to indicate greater brain reward and reinforcing properties of addictive drugs, which are key for addiction in humans . The involvement of DA in BSR is well documented. , For instance, drugs that reduce DA release or block the activation of DA receptors produce effects indicative of a higher brain reward threshold, i.e., attenuated BSR function . Additionally, ICSS itself elevates DA release in the NAc, as is the case with addictive drugs that increase DA neurotransmission. , In contrast, DA antagonists attenuate ICSS responses, along with other drugs that decrease DA levels .…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Our result is similar to the prior finding that both α-PBT and α-PVP facilitate ICSS responses. , In general, a reduced ICSS threshold is considered to indicate greater brain reward and reinforcing properties of addictive drugs, which are key for addiction in humans . The involvement of DA in BSR is well documented. , For instance, drugs that reduce DA release or block the activation of DA receptors produce effects indicative of a higher brain reward threshold, i.e., attenuated BSR function . Additionally, ICSS itself elevates DA release in the NAc, as is the case with addictive drugs that increase DA neurotransmission. , In contrast, DA antagonists attenuate ICSS responses, along with other drugs that decrease DA levels .…”
Section: Discussionsupporting
confidence: 89%
“…26 The involvement of DA in BSR is well documented. 26,45 For instance, drugs that reduce DA release or block the activation of DA receptors produce effects indicative of a higher brain reward threshold, i.e., attenuated BSR function. 46 Additionally, ICSS itself elevates DA release in the NAc, as is the case with addictive drugs that increase DA neurotransmission.…”
Section: Discussionmentioning
confidence: 99%
“…Decades of work with established techniques (microdialysis, voltammetry, electrophysiology) have elucidated the kinetics of electrically-and cue-evoked DA signaling and firing patterns of DA neurons in vivo in response to acute, experimenteradministered or repeated self-administration of alcohol and other drugs of abuse [26][27][28][29][30]. Investigators recently have built on this work by assessing DA responses using dLight during alcohol self-administration [31], and in response to stimulants [32][33][34][35] and opioids [33,36,37]. While FSCV studies in slices [38,39] and in vivo [30,40] have noted the presence of spontaneous DA signals, it has never been possible to assess these events in awake and behaving animals on such a rapid time scale as with dLight.…”
Section: Introductionmentioning
confidence: 99%